secwatch.observer — SEC 8-K summary
======================================

Issuer:     DELCATH SYSTEMS, INC. (DCTH)
CIK:        0000872912
Form:       8-K
Filed at:   2025-05-22T23:59:59+00:00
Accession:  0001193125-25-124538
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Delcath issues 2025 revenue guidance of $94-98M, plans to enter Medicaid drug rebate agreement
--------------------------------------------------------------------------------

- Revenue guidance $94-98M, >150% YoY growth.
- Gross margin 83-85%; positive adjusted EBITDA and cash flow each quarter in 2025.
- Plans to enter NDRA with CMS, effective Q3 2025, expanding Medicaid/340B access.
- CEO expects HEPZATO treatment volume to increase at least 200% in 2025 vs 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/872912/000119312525124538/0001193125-25-124538-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/872912/000119312525124538/d946891d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-124538

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer